Search results
Results from the WOW.Com Content Network
Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]
A major study of dog longevity, which considered both natural and other factors affecting life expectancy, concluded that: "The mean age at death (all breeds, all causes) was 11 years and 1 month, but in dogs dying of natural causes it was 12 years and 8 months.
Canine subvalvular aortic stenosis (SAS) is an abnormal, congenital heart murmur caused by subaortic stenosis (SAS). This genetic trait is polygenic, and in some cases asymptomatic. An animal with SAS may offspring and show no symptoms of the stenosis until multiple generations which is why it is advised not to breed an animal diagnosed with ...
For premium support please call: 800-290-4726 more ways to reach us
Say you have a 4-year-old Labrador named Comet — with the new equation, Comet's real "dog age" would be slightly older than 53. The reason for the difference is actually pretty simple.
Dogs with overt disease may also have episodic weakness and exercise intolerance, but syncope is the predominant manifestation. The third form, which is recognized much less frequently, is characterized by myocardial systolic dysfunction. This may result in left-sided, right-sided, or bi-ventricular congestive heart failure. It is not known if ...
Together with Chief Veterinarian, Dr. Kate Creevy, [2] the project primarily focuses on research to understand dog aging through the collection and analysis of big data through citizen science. Additionally, there is a small component of the project that explores the use of pharmaceuticals to potentially increase life span of dogs.
Said Watt, "Using stem cells from patients with heart failure caused by chemo, we are actively developing new drugs and cell-based treatments that we believe will transform the lives of patients ...